PROS1 and severe acute respiratory syndrome: Ho et al. and Schwarz et al. reported that emodin acts by blocking the binding of SARS-CoV S-protein to the host receptor ACE 2, and suggested that emodin could be considered as a potential lead therapeutic agent for SARS.28,30